, we are concerned with the potential for exploitation of research participants understood as “A exploits B when A takes ‘unfair advantage’ of B”. Exploitation in this sense is transaction specific and concerns the outcome of individual transactions. This account allows for the possibility that a person may be exploited even though she consents to the transaction and also benefits from it. Vulnerability, is neither necessary nor sufficient for exploitation.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- What makes clinical research ethical?.JAMA. 2000; 283: 2701-2711
- The potential exploitation of research participants in high income countries who lack access to health care.Br J Clin Pharmacol. 2016; 81: 847-854
- Exploitation in clinical research.in: Emanuel E.J. Grady C. Crouch R.A. Lie R.K. Miller F.G. Wendler D. The Oxford textbook of clinical research ethics. Oxford University Press, New York2008: 201-210
- Protections for clinical trials in low and middle-income countries need strengthening not weakening.BMJ. 2014; 349: g4254
- Enrolling the uninsured in clinical trials: an ethical perspective.Crit Care Med. 2003; 31: S121-S125
- Disclosure of investigators' recruitment performance in multicenter clinical trials: a further step for research transparency.PLoS Med. 2011; 8e1001149
- Research on prisoners — a comparison between the IOM Committee recommendations (2006) and European regulations.Bioethics. 2010; 24: 1-13
- A systematic review of randomized controlled trials of interventions to improve the health of persons during imprisonment and in the year after release.Am J Public Health. 2015; 105: e13-e33
- Participants in phase 1 oncology research trials: are they vulnerable?.Arch Intern Med. 2008; 168: 16-20
- Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?.J Clin Oncol. 2011; 29: 4045-4053